Division of Neurotoxicology, National Center for Toxicological Research, 3900 NCTR Road, Jefferson, AR 72079, USA.
Division of Neurotoxicology, National Center for Toxicological Research, 3900 NCTR Road, Jefferson, AR 72079, USA.
Neurotoxicol Teratol. 2022 Sep-Oct;93:107119. doi: 10.1016/j.ntt.2022.107119. Epub 2022 Aug 12.
Methylphenidate is a frequently prescribed drug treatment for Attention-Deficit/Hyperactivity Disorder. However, methylphenidate has a mode of action similar to amphetamine and cocaine, both powerful drugs of abuse. There is lingering concern over the long-term safety of methylphenidate, especially in a pediatric population, where the drug may be used for years. We performed a long-term evaluation of the effects of chronic methylphenidate use on a behavioral measure of motivation in male rhesus monkeys. Animals were orally administered a sweetened methylphenidate solution (2.5 or 12.5 mg/kg, twice a day, Mon-Fri) or vehicle during adolescence and into adulthood. These animals were assessed on a test of motivation (progressive ratio responding), during methylphenidate treatment, and after cessation of use. Moreover, animals were evaluated with quantitative T MRI about one year after cessation of use. During the administration phase of the study animals treated with a clinically relevant dose of methylphenidate generally had a higher rate of responding than the control group, while the high dose group generally had a lower rate of responding. These differences were not statistically significant. In the month after cessation of methylphenidate, responding in both experimental groups dropped compared to their previous level of performance (p = 0.19 2.5 mg/kg, p = 0.06 12.5 mg/kg), and responding in the control animals was unchanged (p = 0.81). While cessation of methylphenidate was associated with an acute reduction in responding, group differences were not observed in the following months. These data suggest that methylphenidate did not have a significant impact on responding, but withdrawal from methylphenidate did cause a temporary change in motivation. No changes in T MRI values were detected when measured about one year after cessation of treatment. These data suggest that long-term methylphenidate use does not have a negative effect on a measure of motivation or brain function / microstructure as measured by quantitative T MRI. However, cessation of use might be associated with temporary cognitive changes, specifically alteration in motivation. Importantly, this study modeled use in healthy individuals, and results may differ if the same work was repeated in a model of ADHD.
哌醋甲酯是一种常用于治疗注意力缺陷多动障碍(ADHD)的处方药物。然而,哌醋甲酯的作用模式与安非他命和可卡因相似,而这两者都是强力的滥用药物。人们对哌醋甲酯的长期安全性仍存在担忧,尤其是在儿科人群中,这种药物可能会被使用多年。我们对慢性哌醋甲酯使用对雄性恒河猴的动机行为测量的影响进行了长期评估。动物在青春期和成年期内每天两次(周一至周五)口服服用加糖的哌醋甲酯溶液(2.5 或 12.5mg/kg)或载体。在哌醋甲酯治疗期间和停止使用后,这些动物接受了动机测试(递增比率反应)。此外,在停止使用一年后,使用定量 T 磁共振成像对动物进行了评估。在研究的给药阶段,接受临床相关剂量哌醋甲酯治疗的动物的反应率通常高于对照组,而高剂量组的反应率通常较低。这些差异没有统计学意义。在停止哌醋甲酯使用后的一个月内,与之前的表现相比,两组实验动物的反应均下降(p=0.19,2.5mg/kg;p=0.06,12.5mg/kg),而对照组动物的反应没有变化(p=0.81)。虽然停止哌醋甲酯使用会导致反应急性下降,但在接下来的几个月中并未观察到组间差异。这些数据表明,哌醋甲酯对反应没有显著影响,但停止使用哌醋甲酯确实会导致动机暂时改变。在停止治疗约一年后进行测量时,未检测到 T MRI 值的变化。这些数据表明,长期使用哌醋甲酯不会对定量 T MRI 测量的动机或大脑功能/微观结构产生负面影响。然而,停止使用可能与暂时的认知变化有关,特别是动机的改变。重要的是,本研究模拟了健康个体的使用情况,如果在 ADHD 模型中重复相同的工作,结果可能会有所不同。